Curiously, in hepatocellular carcinoma, AQP9 seems to promote the inhibition of tumor growth and metastasis via the Wnt/β-catenin pathway, standing as a promising therapeutic target for the treatment of this type of cancer [76]. Here, AQP9 is linked to hepatocellular carcinoma.